Reference drugs for triple combination test drug in Russia [Design Issues]

posted by PharmCat  – Russia, 2019-11-16 17:22 (319 d 07:44 ago) – Posting: # 20812
Views: 3,032

» Generic companies did develop almost all attractive double combinations for cardiovasulcar diseases and were trying to expand to triple combinations.

And all this at the moment is a offense against the law.

Complete thread:

 Admin contact
21,090 posts in 4,398 threads, 1,469 registered users;
online 10 (1 registered, 9 guests [including 4 identified bots]).
Forum time: Thursday 02:07 CEST (Europe/Vienna)

In these days, a man who says a thing cannot be done
is quite apt to be interrupted by some idiot doing it.    Elbert Green Hubbard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz